Physician profile
Michael Casey Smith
NPI 1336698851
$1,451.98
in general payments reported to CMS, 2019-2025
11 companies · $243 in 2025
The $243 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $258 · 2022: $346 · 2023: $245 · 2024: $360 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $848.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $847.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $303.37 | 2021-2024 | Cardiomems |
| Actelion Pharmaceuticals US, INC. | $246.36 | 2022-2023 | Uptravi, Opsumit |
| Boston Scientific Corporation | $136.78 | 2024 | Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $126.95 | 2025 | Camzyos |
| Biosense Webster, INC. | $121.93 | 2022 | |
| Novo Nordisk INC | $115.82 | 2025 | Ozempic |
| Edwards Lifesciences Corporation | $102.82 | 2023 | Sapien 3 Ultra Resilia |
| Abiomed | $99.70 | 2022 | |
| Amgen INC. | $94.35 | 2024 | Repatha |
| Astrazeneca Pharmaceuticals Lp | $90.73 | 2024 | Farxiga |
| Medtronic, INC. | $13.17 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.